Federal Data HubHRSA 340B · JSON

Kapiolani Medical Center for Women and Children

Hemophilia and Thrombosis Treatment Center of Hawaii · 340B ID HM96826

ParticipatingHemophilia Treatment Center

Kapiolani Medical Center for Women and Children is a Hemophilia Treatment Center enrolled in the federal 340B Drug Pricing Program in Honolulu, HI. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 8 contract-pharmacy arrangement(s) (7 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (8)

PharmacyLocationBeginTerminatedPharmacy ID
ACCREDO HEALTH GROUP INCTEMPE, AZ2020-04-0175292
ACCREDO HEALTH GROUP INCWARRENDALE, PA2020-04-0123041
ACCREDO HEALTH GROUP INCMEMPHIS, TN2020-04-0145979
ACCREDO HEALTH GROUP, INC.NEWARK, DE2020-04-0198337
ACCREDO HEALTH GROUP, INC.HONOLULU, HI2020-01-01122681
ACCREDO HEALTH GROUP, INC.LENEXA, KS2020-04-0162883
HAWAII PACIFIC HEALTH SPECIALTY PHARMACYHONOLULU, HI2023-10-012024-05-31137377
PHARMACAREHONOLULU, HI2013-07-0184127

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.